摘要:
7-ACYLAMIDO CEPHALOSPORANIC ACIDS AND NON-TOXIC SALTS THEREOF HAVING A THIOETHER GROUP AT THE 3-POSITION, THE ACYL GROUP IN THE 7-SUBSTITUENT BEING OF THE ALIPHATIC, HETEROCYCLIC ARALIPHATIC CONTAINING 1 TO 2 HETERO ATOMS, ARALIPHATIC OR CYCLOALIPHATIC SERIES, AN ARALIPHATIC ACYL GROUP HAVING AN ATOMIC WEIGHT SUM OF AT LEAST 120 WHEN THE ARYL MOIETY THEREOF IS A CARBOXYLIC AROMATIC GROUP. SUCH COMPOUNDS ARE ANITBIOTICS MORE RESISTANT TO METABOLIC PROSSESS REDUCING ANTIBIOTIC ACTIVITY THAN ARE CEPHALOSPORINS POSSESSING A 3-ACETOXYMETHYL GROUP AND CERTAIN OF THEM SHOW SIGNIFICANT ABSORPTION AFTER ORAL ADMINISTRATION.
摘要:
7 Beta -Acylamidoceph-3-em-4-carboxylic acids having an etherified 3-hydroxymethyl group, physiologically acceptable base or acid addition salts thereof and intermediates for the preparation of the acids and salts.
摘要:
7 Beta -ACYLAMIDOCEPH-3-EM-4-CARBOXYLIC ACIDS HAVING A THIOETHERIFIED METHYL GROUP AT THE 3-POSITION AND PHYSIOLOGICALLY ACCEPTABLE DERIVATIVES THEREOF. The compounds have utility as antibiotics and show significant absorption after oral administration.
摘要:
Novel semisynthetic thiazolidine derivatives of formula
WHERE R1 is the residue of an acyl group R1CO- containing 1-21 carbon atoms are provided by reduction of the corresponding Delta 3-thiazoline, the thiazolidine derivatives being of use in the production of cephalosporins, penicillins and related Beta lactam antibiotics. The preparation and use of such thiazolines and thiazolidines in N-protected forms are also described. The Delta 3-thiazoline starting materials may be obtained from penicillins without changing the configuration of the Beta lactam structure desired in the final product.
摘要:
7B-AMINO- AND ACYLAMIDOCEPH-3-EM-4-CARBOXYLIC ACIDS HAVING AT THE 3-POSITION A HALO-, FORMYLOXY-, ISOTHIOCYANATO- OR HALOACETOXYMETHYL GROUP AND SALTS AND ESTERS THEREOF. THESE COMPOUNDS ARE USEFUL AS STARTING COMPOUNDS FOR PREPARING 7B-ACYLAMIDOCEPH-3-EM-4-CARBOXYLIC ACIDS HAVING A GROUP AT THE 3-POSITION, OTHER THAN 3-ACETOXYMETHYL, BY REACTION WITH A NUCLEOPHILE. THE COMPOUNDS PREPARED HAVE MODIFIED ANTIBIOTIC ACTIVITY.
IN WHICH AR REPRESENTS AN AROMATIC GROUP HAVING AN ATOMIC WEIGHT SUM OF AT LEAST 78 AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND A-CARBONYL DERIVATIVES.